Survodutide
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Boehringer Ingelheim · Phase 1 · Active, not recruiting · Enrollment 29
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Group 1: BI 456906 | n/r | n/r | n/r | n/r |
| Group 2: Semaglutide | n/r | n/r | n/r | n/r |
| Group 3: BI 456906 | n/r | n/r | n/r | n/r |
| Group 4: Semaglutide | n/r | n/r | n/r | n/r |
Not shown
- Group 1: BI 456906: endpoint not reported
- Group 2: Semaglutide: endpoint not reported
- Group 3: BI 456906: endpoint not reported
- Group 4: Semaglutide: endpoint not reported